BSc Hons Accounting and Management
Queen Mary University of London's BSc-Hons- Accounting and Management program ...
Charterhouse Square
INTAKE: September
The MSc in Cancer and Therapeutics program at Queen Mary University is designed to provide students with a comprehensive and multidisciplinary understanding of cancer biology, therapeutics, and research methodologies. The program encompasses a broad spectrum of courses that equip students with the knowledge and skills required to contribute to the development of innovative cancer treatments.
Cancer Biology: Students delve into the fundamental mechanisms of cancer, exploring the molecular and cellular processes underlying its development, progression, and metastasis.
Therapeutic Strategies: The program introduces students to a variety of cancer treatment modalities, including chemotherapy, targeted therapies, immunotherapy, and gene therapy.
Personalized Medicine: Students learn about the concept of personalized medicine and how it is transforming cancer treatment by tailoring therapies to individual patients based on genetic and molecular profiles.
Cancer Immunology: The curriculum covers the interaction between the immune system and cancer cells, as well as the development of immunotherapeutic approaches to treat cancer.
Clinical Trials and Drug Development: Students gain insights into the process of drug discovery, development, and clinical trials, exploring the regulatory and ethical aspects of bringing new cancer therapies to patients.
Genomics and Precision Oncology: The program delves into genomics technologies and their application in precision oncology, enabling students to analyze cancer genomes and identify potential therapeutic targets.
Research Techniques: Students acquire practical skills in laboratory techniques, data analysis, and bioinformatics relevant to cancer research.
Translational Cancer Research: The curriculum emphasizes the translation of basic research findings into clinical applications, bridging the gap between laboratory discoveries and patient care.
Emerging Trends: Students explore emerging trends and advancements in cancer research and therapeutics, staying informed about the latest breakthroughs in the field.
Research Project: The program culminates in a research project, allowing students to conduct original research under the guidance of experienced faculty, contributing to the growing body of knowledge in cancer biology and therapy.
Charterhouse Square
IELTS 6.5
£ 26750
Postgraduate Entry Requirements:
Students must provide:
Work experience: Some postgraduate courses may require relevant work experience in the field.
It is important to note that meeting the minimum entry requirements does not guarantee admission, as the university considers factors such as availability of places and competition for the program. Additionally, some courses may have higher entry requirements or additional selection criteria, such as interviews or portfolio submissions.
Queen Mary University of London offers a range of scholarships and bursaries to its students.
Graduates of the MSc Cancer and Therapeutics program from Queen Mary University are well-prepared to embark on rewarding and impactful careers in the field of oncology.
Clinical Research Scientist: Graduates can work as clinical research scientists, conducting trials to test new cancer therapies and contributing to the development of novel treatments.
Medical Affairs Specialist: Graduates may pursue roles in medical affairs, engaging with healthcare professionals and providing scientific support for cancer therapies.
Pharmaceutical Industry: Graduates can join pharmaceutical companies in roles such as medical liaison, medical writing, or regulatory affairs, ensuring the safe and effective use of cancer treatments.
Academic Researcher: Graduates interested in academia can pursue research positions at universities and research institutes, contributing to the advancement of cancer knowledge.
Cancer Genetic Counselor: Graduates with expertise in genomics and precision oncology can work as genetic counselors, providing guidance to patients and families regarding cancer risk and treatment options.
Biotechnology Entrepreneur: Graduates with innovative ideas can establish biotech startups focused on developing new cancer therapies or diagnostics.
Healthcare Policy Advisor: Graduates may contribute to healthcare policy and advocacy organizations, influencing decisions related to cancer treatment and patient care.
Hospital or Clinical Laboratory Scientist: Graduates can work in hospital or clinical laboratories, conducting diagnostic tests and analyzing patient samples to aid in cancer diagnosis and treatment.
PhD Research: Graduates can pursue doctoral studies, conducting in-depth research in specialized areas of cancer biology or therapy.
Patient Advocacy: Graduates may engage in patient advocacy and support organizations, helping to raise awareness about cancer prevention, treatment, and survivorship.